1. Targets for AD treatment: conflicting messages from γ-secretase inhibitors;Sambamurti;J Neurochem,2011
2. Recent progress in understanding Alzheimer’s β-amyloid structures;Fändrich;Trends Biochem Sci,2011
3. Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
4. Increased tau accumulation in senile plaques as a hallmark in Alzheimer’s disease;Shin;Am J Pathol,1989
5. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice;Yu;J Alzheimers Dis,2011